ITRIItron, Inc.
Is the price fair?
Undemanding: modest expectations priced in, cheap against its own history, and cheap vs its sector.
Priced for a decline (~−4% a year). The price demands less than its three-year revenue growth of 6% a year, expectations look modest.
Cheap vs its own history: P/E 14.3 vs a 37.2 median over 25 quarters (−61% vs median).
Sector median 30.5× across 203 covered peers. EV/EBIT counts debt as part of the price, so a cash-rich and a borrowed company can be compared on the same footing.
Unless marked, from derived, as of Jun 30, 2026.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What ITRI's price assumes
Itron, Inc. trades at 14.3× earnings against 38.2× for the median Scientific & Technical Instruments name, cheaper than its own group.
Trailing P/E · Scientific & Technical Instruments median 38.2 · cheaper than the typical name in its group
- Price / sales
- 1.60
Price / sales · today's price, trailing year to Jun 30, 2026
- Free cash flow yield
- 10%
Free cash flow yield · Scientific & Technical Instruments median 4.0%
- Growth the price implies
- −4.3%
Growth the price implies · The price pays for −4.3% free cash flow growth a year for a decade; the business has delivered +155% a year over the last three.
Details›
- Price / booktoday's price, trailing year to Jun 30, 2026
- 2.28
- EV / EBITtoday's price, trailing year to Jun 30, 2026
- 14.8
- EV / salestoday's price, trailing year to Jun 30, 2026
- 1.96
- Technology median P/E459 names
- 37.7
- Scientific & Technical Instruments median P/E18 names
- 38.2
- Free cash flow, trailing twelve months
- $385M
- Market capitalisation
- $3.68B
- 3-year revenue growth
- +6.2%
- 3-year free cash flow growth
- +155%
| Method | Per share |
|---|---|
| What its own history would imply | not meaningful, 14.3× today against a 37.2× median |
| 52-week range | $78.02 – $138.18 |
| Today | $85.61 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Scientific & Technical Instruments
Ranks #4 of 12 by RyuScore